You are here

Daniel J. Lenihan, MD
 - heart puzzle

A research team at Vanderbilt University School of Medicine has partnered with Acorda Therapeutics to evaluate the safety and efficacy of a new biological product that has the potential to treat patients with even severe, progressive heart failure.